Literature DB >> 25969924

Sex-Specific Predictors of Metabolic Syndrome Independent of Its Components.

Altan Onat1, Günay Can, Hakan Çakr, Fatma Özpamuk-Karadeniz, Yusuf Karadeniz, Hüsniye Yüksel, Barş Şimşek, Evin Ademoğlu.   

Abstract

To what extent is the metabolic syndrome (MetS) determined beyond its recognized components? In 1702, middle-aged men and women without MetS at baseline, MetS development was identified in 546 participants at a mean of 10.1-year follow-up. Participants subsequently developing MetS had, beyond higher values of MetS traits, significantly higher total and low-density lipoprotein cholesterol, apolipoprotein B, C-reactive protein (CRP), γ-glutamyl transferase (GGT), and lower high-density lipoprotein cholesterol. Females were significantly more frequent never smokers and males had lower values of total testosterone. In logistic regression analyses, adjusted for sex, age, and smoking status, MetS was predicted disparately in the sexes, whereas males exhibited, beyond abdominal obesity, CRP, GGT, and sex hormone-binding globulin (SHBG) as independent predictors, abdominal obesity was not an independent predictor in females in whom other than age, CRP conferred MetS risk, whereas SHBG was and current smoking tended to be protective. A surrogate of hepatic steatosis proved a major mediator of abdominal obesity in determining incident MetS (relative risk, 5.6 [95% confidence interval, 3.4-9.3]) in each sex. We confirm that GGT and SHBG are novel independent MetS determinants. Hepatic steatosis is the major predictor of MetS mediating adiposity in each sex. Abdominal obesity is not an independent determinant in Turkish women in whom autoimmune activation seems to prevail before MetS development.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25969924     DOI: 10.1097/JIM.0000000000000203

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  2 in total

1.  Relation of Biochemical Parameters with Flow-mediated Dilatation in Patients with Metabolic Syndrome.

Authors:  Nurver Turfaner Sipahioglu; Barıs Ilerigelen; Zeynep B Gungor; Gulsel Ayaz; Hakan Ekmekci; Cigdem Bayram Gurel; Gunay Can; Huseyin Sonmez; Turgut Ulutin; Fikret Sipahioglu
Journal:  Chin Med J (Engl)       Date:  2017-07-05       Impact factor: 2.628

2.  Does the low-density lipoprotein cholesterol play a key role in predicting metabolic syndrome in the Iranian adult population?

Authors:  Karimollah Hajian-Tilaki; Behzad Heidari; Arefeh Hajian-Tilaki; Alireza Firouzjahi; Afsaneh Bakhtiari
Journal:  Caspian J Intern Med       Date:  2017
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.